The Lahey Institute of Urology is equipped with a daVinci ® Surgical System, a computerized robotic platform that enhances the performance of laparoscopic prostatectomy.
As with traditional laparoscopic surgery, the surgeon operates through tiny incisions in the patient's abdomen. The daVinci System serves as extensions of the surgeon’s hands, and is designed to filter and translate the surgeon’s hand movements into precise movements of instruments within the surgical site.
Surgical performance is enhanced by the elimination of some of the physical challenges posed by traditional laparoscopic surgery. The daVinci System can improve the surgeon’s visualization of delicate tissues and nerves by providing him or her with a magnified, 3D view of the surgical site. It also increases the surgeon's dexterity by allowing for 360-degree rotation of surgical tools.
The daVinci System is the only surgical robotic system approved by the United States Food and Drug Administration for use in performing radical prostatectomy, as well as a range of other procedures.
David Canes, MD, is the medical director of the Lahey Institute of Urology at Parkland Medical Center. He is fellowship-trained in advanced laparoscopic and robotic urology, and as of January 2015 has performed more than 850 robotic prostatectomy procedures, and a total of more than 1,000 robotic surgeries using the da Vinci® Surgical System. Dr. Canes has helped other surgeons learn the technique of robotic prostatectomy both regionally and abroad.
Dr. Canes attended medical school at the Weill Medical College of Cornell University and went on to complete a six-year Urology residency training program at Lahey Clinic Medical Center. Following residency, Dr. Canes pursued additional subspecialty fellowship training at the Glickman Urological and Kidney Institute of Cleveland Clinic, a world-renowned center for minimally invasive surgery. Under the mentorship of Mihir Desai, MD, and Inderbir Gill, MD, MCh, he specialized in advanced laparoscopy, robotic surgery and endourology. Subsequently, Dr. Canes was recruited to join the staff at the Institute of Urology at Lahey Clinic.
Dr. Canes practices at the Institute of Urology at Lahey Hospital & Medical Center in Burlington, Massachusetts, and the Lahey Institute of Urology at Parkland Medical Center in Derry, New Hampshire, which he established in 2008 and now serves as Medical Director. He primarily focuses on minimally invasive and robotic surgery for urologic cancers, including prostate, bladder, kidney, ureteral and adrenal tumors, although his training encompassed open surgery, as well. Dr. Canes's specialty training also includes the endourologic management of complex kidney and ureteral stones.
Dr. Canes has published extensively in the field of minimally invasive urologic surgery, and has presented his work at national and international meetings. He is a member of several professional societies including the American Urological Association and the Endourology Society.
Ali Moinzadeh, MD, is the director of robotic surgery at Lahey Hospital & Medical Center. He is formally trained in the management of urologic cancers and uses the latest surgical techniques with robotic and laparoscopic surgery to minimize patient morbidity. He has used the da Vinci ® robotic platform for over 13 years. He completed a two-year fellowship in Advanced Robotic and Laparoscopic Surgery at the prestigious Glickman Urologic and Kidney Institute, Cleveland Clinic from 2003 to 2005. As of October 2016, he has performed over 2,200 minimally invasive surgical procedures, including over 1,500 radical prostatectomies, as well as kidney, adrenal ureter, and bladder surgeries. He played an integral part in the development and refinement of techniques for erectile nerve preservation during prostate removal for cancer while working with the world-renowned Inderbir S. Gill at the Cleveland Clinic.
Dr. Moinzadeh received his undergraduate degree with highest distinction from the University of Michigan in Ann Arbor. He earned his medical degree from Northwestern University Medical School in Chicago in 1997. Prior to his current position at Lahey Hospital & Medical Center, Dr. Moinzadeh completed two years of general surgery training at Massachusetts General Hospital, followed by four years of urology residency at Lahey Clinic. After completion of his subspecialty fellowship, he served as chief of robotic and laparoscopic surgery at the State University of New York (SUNY) Upstate Medical Center. At SUNY, he helped establish the robotics program and built one of the busiest minimally invasive urologic cancer programs in upstate New York.
At Lahey Hospital & Medical Center, Dr. Moinzadeh performed the first robotic partial nephrectomy for kidney cancer in 2007 - the first experience in New England - as well as the first robotic radical cystectomy, for bladder cancer, and the first laparoscopic renal tumor cryoablation, for kidney cancer. In 2008, under Dr. Moinzadeh's guidance, Lahey's Institute of Urology acquired one of the world's first surgical robotic simulators to aid in robotic training. Besides the treatment of urologic malignancies, he has one of the highest levels of experience in the world for the treatment of adult ureteral stricture disease using the daVinci® surgical robot. He is one of the few urologists in New England with significant experience in performing retroperitoneal kidney surgery, useful in patients with multiple prior abdominal surgeries.
Dr. Moinzadeh has extensively traveled the United States, proctoring and mentoring other surgeons interested in robotic surgical training in prostatectomy, pyeloplasty, and partial nephrectomy. He has published more than 40 peer-reviewed manuscripts and authored more than 10 book chapters focusing on minimally invasive urologic oncology. He has presented and lectured at numerous scientific meetings. He is a reviewer for several urologic journals and is on the editorial board of the Canadian Journal of Urology. In 2007, he completed the program in clinical effectiveness (epidemiology, biostatistics, and health policy) at Harvard School of Public Health. Current research endeavors include the tracking of surgical data for outcomes reporting.
Andrea Sorcini, MD, is a specialist in the fields of minimally invasive surgery and urologic oncology. He joined the Urology Institute in 2000, after completing his urology residency and transplant fellowship at Lahey Clinic. Today, he is actively involved in the Kidney Transplant Program, Prostate Center and Center for Minimally Invasive Urologic Surgery.
Dr. Sorcini has performed many laparoscopic and open kidney operations and transplants. Under his direction, the volume of kidney transplants at Lahey Hospital & Medical Center nearly quadrupled in the early 2000s. Today he focuses primarily on urologic oncology and laparoscopic removal of cancers of the bladder, prostate, kidney and adrenal gland.
Dr. Sorcini is a graduate of the University of Rome, La Sapienza School of Medicine in Italy, where he completed a residency in general surgery in 1993. He has published many scholarly articles in the field of urologic oncology, along with videos on clinical and technical aspects of urology that have won several awards at international conferences.
Learn more about the patient-centered, high-quality approach to prostate cancer care provided to patients diagnosed and treated at Lahey Clinic.